The Multitalented Marvels: Exploring the Versatile Potential of Natural Products in Osteosarcoma Treatment.

IF 2.1 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY
Cancer Informatics Pub Date : 2026-07-31 eCollection Date: 2026-01-01 DOI:10.1177/11769351261474027
Chenxu Jia, Qingtao Meng, Mingna Huo, Fengping Zhang, Jian Han
{"title":"The Multitalented Marvels: Exploring the Versatile Potential of Natural Products in Osteosarcoma Treatment.","authors":"Chenxu Jia, Qingtao Meng, Mingna Huo, Fengping Zhang, Jian Han","doi":"10.1177/11769351261474027","DOIUrl":null,"url":null,"abstract":"<p><p>Osteosarcoma (OS) is a malignant neoplasm arising from bone tissue. The OS exhibited a significant degree of heterogeneity, with a high incidence of local invasion and a high rate of metastasis. Approximately 25% of those diagnosed with OS present with metastases, with the lungs being the most prevalent site, followed by the bones or lymph nodes. The 5-year survival rate for patients with OS with lung metastasis is only 10% to 30%. Adjuvant chemotherapy regimens significantly enhanced the 5-year survival rate in patients diagnosed with non-metastatic OS. However, the same regimens did not provide a substantial improvement in survival for patients with OS who had acquired lung metastasis or had recurrence. Moreover, the extensive use of chemotherapy medications often results in the development of resistance to chemotherapy in patients with OS, which frequently culminates in treatment ineffectiveness. Natural products (NPs) are significant reservoirs of anti-cancer medications. Preclinical investigations have shown that certain NPs had substantial promise for treating OS. However, there is currently a lack of a comprehensive overview of the use of NPs in OS treatment. In this review, we provide a comprehensive overview of the NPs, which include polyphenols, alkaloids, and terpenoids, that have the potential to be effective in the treatment of OS.</p>","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":"25 ","pages":"11769351261474027"},"PeriodicalIF":2.1000,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13428158/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11769351261474027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Osteosarcoma (OS) is a malignant neoplasm arising from bone tissue. The OS exhibited a significant degree of heterogeneity, with a high incidence of local invasion and a high rate of metastasis. Approximately 25% of those diagnosed with OS present with metastases, with the lungs being the most prevalent site, followed by the bones or lymph nodes. The 5-year survival rate for patients with OS with lung metastasis is only 10% to 30%. Adjuvant chemotherapy regimens significantly enhanced the 5-year survival rate in patients diagnosed with non-metastatic OS. However, the same regimens did not provide a substantial improvement in survival for patients with OS who had acquired lung metastasis or had recurrence. Moreover, the extensive use of chemotherapy medications often results in the development of resistance to chemotherapy in patients with OS, which frequently culminates in treatment ineffectiveness. Natural products (NPs) are significant reservoirs of anti-cancer medications. Preclinical investigations have shown that certain NPs had substantial promise for treating OS. However, there is currently a lack of a comprehensive overview of the use of NPs in OS treatment. In this review, we provide a comprehensive overview of the NPs, which include polyphenols, alkaloids, and terpenoids, that have the potential to be effective in the treatment of OS.

多才多艺的奇迹:探索天然产物在骨肉瘤治疗中的多功能潜力。
骨肉瘤(Osteosarcoma, OS)是一种起源于骨组织的恶性肿瘤。OS表现出明显的异质性,局部侵袭率高,转移率高。在被诊断为OS的患者中,约有25%存在转移,肺是最常见的部位,其次是骨骼或淋巴结。伴有肺转移的OS患者5年生存率仅为10% ~ 30%。辅助化疗方案显著提高非转移性OS患者的5年生存率。然而,同样的方案并没有为获得肺转移或复发的OS患者的生存提供实质性的改善。此外,化疗药物的广泛使用往往导致OS患者对化疗产生耐药性,最终导致治疗无效。天然产物(NPs)是抗癌药物的重要储存库。临床前研究表明,某些NPs对治疗OS有很大的希望。然而,目前缺乏对NPs在OS治疗中的使用的全面概述。在这篇综述中,我们提供了一个全面的概述NPs,其中包括多酚,生物碱和萜类化合物,有可能是有效的治疗OS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Informatics
Cancer Informatics Medicine-Oncology
CiteScore
3.00
自引率
5.00%
发文量
30
审稿时长
8 weeks
期刊介绍: The field of cancer research relies on advances in many other disciplines, including omics technology, mass spectrometry, radio imaging, computer science, and biostatistics. Cancer Informatics provides open access to peer-reviewed high-quality manuscripts reporting bioinformatics analysis of molecular genetics and/or clinical data pertaining to cancer, emphasizing the use of machine learning, artificial intelligence, statistical algorithms, advanced imaging techniques, data visualization, and high-throughput technologies. As the leading journal dedicated exclusively to the report of the use of computational methods in cancer research and practice, Cancer Informatics leverages methodological improvements in systems biology, genomics, proteomics, metabolomics, and molecular biochemistry into the fields of cancer detection, treatment, classification, risk-prediction, prevention, outcome, and modeling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书